in SK-N-MC human neuroblastoma cells in response to gluta mate. Chlomethiazole inhibited the p38 MAP kinase activity as revealed by the decrease in the LPS-induced phosphorylation of the substrates ATF-2 and hsp27, whereas the phosphoryla tion status of the p38 MAP kinase itself was unaffected. Inter estingly, chlomethiazole exhibited an ICso of -2 f-LmollL for inhibition of c-fos mRNA expression, indicating 25 to 75 times higher potency than reported ECso values for enhancing GABAA chloride currents. The results indicated a novel mecha nism of action of chlomethiazole, and provided support for a distinctive role of p38 MAP kinase in cerebral ischemia. Key Words: Chlomethiazole-Neuroprotection-Stroke-p38 MAP kinase-Astrocytes-Lipopolysaccharide.
JNKs and p38 MAPKs were shown to be activated downstream of cytokine receptors, such as tumor ne crosis factor (TNF) and interleukin-l (IL-l) receptors (Saklatvala et aI., 1996; Yuasa et aI., 1998) , and other forms of stress like UV irradiation, H202> osmotic stress, and ischemia-hypoxia (Woodgett et aI., 1995; Mizukami et aI., 1997) . In particular, p38 MAP kinase activity, a target of a group of cytokine-suppressant anti-inflam matory drugs (CSAIDs), such as the pyridinyl imidazole compound SB203580 (Lee et aI., 1994; Kumar et aI, 1999) , has been correlated with apoptotic cell death in cerebellar granule cells and other neuronal cells in response to glutamate (Xi a et al.. 1995; Kawasaki et aI., 1997) , and its inhibition resulted in protection of cultured cardiac myocytes from ischemic injury (Mackay and Mochly-Rosen, 1999) . In a recent review, raise the therapeutic potential for p38 MAP kinase inhibitors in stroke because of the inhibition of the production of the inflammatory cyto kines IL-l f3 and TNF-ex, and their effect against neuronal apoptosis.
Only recently has the role of inflammatory mediators in ischemic injury in cell death and survival been real ized. Direct trauma, ischemia, neurotoxicity, viral or bac-terial infection, or immunologic challenge share a com mon denominator-the brain's inflammatory response, namely activated glial cells which secrete cytokines. For instance, bacteria-derived lipopolysaccharide (LPS) trig gers the inflammatory response by activating the tran scription factor NFKB and the subsequent production of the major proinflammatory cytokines IL-l[3 and TNF-a by glial cells (Gatti and Bartfai, 1993; Wan et aI., 1994; Quan, 1999) , as well as the activation of all subgroups of MAP kinases in monocytes, macrophages, and astrocytes (Willis and Nisen, 1996; Schumann et aI., 1998) . Inter estingly, NF-KB inhibition has been shown as a potential mechanism of neuroprotection exerted by aspirin and salicylates (Grilli et aI., 1996) , whereas IL-l[3 receptor antagonists have been shown to be neuroprotective in several models of ischemia in the rat (Relton and Rothwell, 1992) . Significant p38 MAP kinase activation has been demonstrated to occur within the ischemic cor tex predominantly in astrocytes, in a middle cerebral ar tery occlusion rat model (Irving et aI., 1999) , but also in microglial cells surrounding dying, vulnerable CA 1 hip pocampal neurons, in a gerbil model of global ischemia (Walton et aI., 1998) . Recently, while inhibiting p38 ac tivation during ischemia by using SB239063, have shown significantly reduced brain injury and neurologic deficits in the rat middle cerebral artery occlusion model.
Lipopolysaccharide administration also induces, through MAP kinases, the expression of the immediate early genes fo s and jun resulting in the activation of the transcription factor AP-l (Han et ai, 1997; Hazzalin et ai, 1997 ). Both fo s and jun family genes have been studied in models of experimental ischemia, mostly in rodents, in which inhibition of c-fos expression by antisense oligo nucleotides and targeted disruption of the JNK-3 gene have resulted in a substantial degree of neuroprotection from excitotoxic insults (Chiasson et aI., 1997; Lu et aI., 1997; Yang et al., 1997) .
Chlomethiazole (CMZ) is a hypnotic sedative and anxiolytic agent (Cross et al., 1989; Moody and Skol nick, 1989 ) that has neuroprotective properties in several models of focal and global ischemia in rodents (reviewed by Green, 1998) . Most importantly, CMZ has been effi cacious when administered four hours after the ischemic insult. Recently, a report of a clinical trial of CMZ sug gested a clinical benefit of treatment with the compound of patients with severe stroke (Wahlgren et aI., 1999) .
The authors reported here that CMZ attenuates the activation of c-fos/c-junJ AP-l through inhibition of p38 MAP kinase activity. In view of the important roles of p38 MAP kinase in ischemic injury, the authors sug gested that the anti-inflammatory properties of CMZ might be of relevance for the neuroprotection seen by CMZ in vivo. Vol. 20, No. 7, 2000 
MATERIALS AND METHODS

Chemicals
Chlomethiazole was a gift from Dr. Ylva Terelius, Astra Zeneca, Sodertalje, Sweden. Lipopolysaccharide (from E. Coli 0127:B8) and TPA were purchased from Sigma, St. Louis, MO, U.S.A. SB203580 (4-(4-Fluorophenyl)-2-(4-methyl sulfinylphenyl)-5-( 4-pyridyl) I H-imidazolc) was purchased from Calbiochem, CA, U.S.A.
Cell culture
Rat primary cortical glial cultures were established from cor tices of newborn rats (6 to 12 hours) as previously described (Tindberg et aI., 1996) . The cells were grown in minimum essential medium supplemented with 20% fetal calf serum, amino acids, vitamins, D-glucose (5 mmollL), penicillin (100 JU/mL), and streptomycin (100 /-Lg/mL). SK-N-MC human neuroblastoma cells were purchased from American Type Cul ture Collection (ATCC, Manassas, VA, U.S.A.) and grown in minimum essential medium supplemented with 10% fetal calf serum, 2.2 gIL of sodium pyruvate, 0.1 mmollL nonessential amino acids, penicillin (100 IUlmL), and streptomycin (100 /-Lg/mL). All media for cell culture were from Life technologies Rockville, MD, U.S.A. Primary cortical glial cells were fixed with 2% paraformaldehyde and incubated with two different antibodies reactive towards glial fibrillary acidic protein (GFAP; Dakopatts A/S, Denmark) or CDllb (Biosource inter national); subsequently, a secondary TRITC-Iabeled antibody (Boehringer Mannheim, Germany) was used. Cells were also stained with propidium iodide and the primary cortical glial cultures were found to contain -85% GFAP + cells (astrocytes) and -3% CD II b + cells (microglial cells). All experiments in volving the establishment of primary cortical glial cultures were approved by the ethical committee for animal studies at Karolinska Institutet.
Quantitative RT -PCR and Northern blot
Total RNA was isolated from primary cortical glial cells cultured on 150-mm culture dishes by the guanidium isothio cyanate method (Chomczynski and Sacchi, 1987) . The RNA was subjected to electrophoresis on a 1.2% agarose formaldehyde denaturing gel (40 /-Lg per lane), transferred onto nitrocellulose filter, and hybridized with radiolabeled cDNA probes for c-fos, c-jun, and l3-actin, as described by Struhl
(1 993b). The probes were obtained by polymerase chain reac tion (PCR) amplification of cDNA derived from the same cells and were labeled with (a_ 3 2 P(dCTP (3000 CilmmollL, Amer sham, U.K.) using the Radprime DNA labeling system (Life). The primers used to obtain the probes were the same as for the quantitative PCR analysis (see below).
For the quantitative reverse transcriptasc polymerase chain reaction (RT-PCR) analysis, I /-Lg of total RNA was reverse transcribed using an oligo-dT primer (18-mer). The RT reaction was performed at 42°C using the Ist™ strand cDNA synthesis kit (CLONTECH). Quantitative PCR analysis of the relative amount of the c-fos or c-jun mRNA in differently treated pri mary cortical glial cells was performed using the PCR mimic 228 kit (CLONTECH, Palo Alto, CA, U.S.A.). The primers used in the PCR analysis corresponded to the exon I DNA sequences of the rat c-fos gene,S' -CTT GAA GAC GAG AAG TCT GCG -3' for the upstream primer, and 5' -GGT CAT TGA GAA GAG GCA GG -3' for the downstream primer (also described by Yu et aI., 1995) . The c-fos cDNA fragment. 226 bp long, was amplified in the presence of decreasing concen trations of a 546 bp DNA standard (mimic DNA, constructed by PCR amplification of a Bam HI-EcoRI restriction fragment of the v-erbB gene, as described in the PCR mimic™ construc-tion kit). The primers for c-jun corresponded to the following DNA sequences in exon I of the rat c-jun gene: 5' -AAC AGA TCC CGG TGC AGC AC -3' for the upstream, and 5' -CCA CCT GTT CCC TGA GCA TG -3' for the downstream primer.
The c-jun fragment of 279 bp, was coamplified with a mimic DNA fragment of 546 bp as described also for c}os. The PCR amplification was conducted in a Perkin Elmer amplifier (Per kin Elmer, Norwallk, CT, U.S.A.) under the following thermal cycle conditions: 45 seconds denaturing at 94°C, 45 seconds annealing at 57°C, and I minute extension at noc for 37 cycles, followed by 7 minutes final extension at n°c. The PCR products were analyzed on a 1.6% agaroserrBE gel, and the negatives of Polaroid photographs (Polaroid, Cambridge, MA, U.S.A.) of the Ethidium Bromide-stained gels were scanned using a laser densitometer (Molecular Dynamics, U.S.A.). The levels of c-fos and c-jun mRNAs were calculated as the con centration of the mimic DNA required to reach an equal density of the target and mimic bands by examining the relative inten sities between target and mimic in reactions carried out at 3 to 4 different mimic DNA concentrations. The IL-I [3 primers used corresponded to the following sequences of the rat IL-I [3 eDNA: 5'-GAC CTG TTC TTT GAG GCT GAC -3' and 5' TIC ATC TCG AAG CCT GCA GTG -3' for the upstream and the downstream primer respectively, and the quantitation pro cedure followed the same principles as described above. The TNF-a primers used corresponded to the following sequences in the rat TNF-a gene: 5' -ACG CTC TTC TGT CT A CTG-3' (exon-I) and 5'-GGA TGA ACA CGC CAG TCG-3' (exon 4) for the forward and the reverse primer respectively. The results of all PCR quantitations were normalized by the [3-actin con tent of each sample which was also quantified by RT-PCR mimic system (for primer sequence and experimental setup see Fang et aI., 1998) .
Cell extracts and Western blot
Rat primary cortical glial cultures were stimulated with LPS (100 ng/mL). After stimulation, cells were immediately put on ice, washed, and harvested in lysis buffer containing 20 mmollL Tris-HCI pH 7.4, 137 mmollL NaC!, 10% glycerol, 1% Triton XIOO, I mmollL Na 3 V04, 5 mmollL NaF, 10 mmollL Na 2 Mo04, 2 mmollL EDT A and I mmol/L phenylmethyl sulphonylfluoride (PMSF). Lysed cells were left at +4°C for 30 minutes with slight shaking, followed by centrifugation of the material for 15 minutes at 1O.000x g, at +4 DC. The protein content of the Triton X-100 soluble fractions was determined according to the Lowry method. Proteins were separated in a 12% sodium dodecyl sulfate-polyacrylamide gel electrophore sis (SDS-PAGE) on a Bio-Rad Protean II apparatus at 100 V (Biorad, CA, U.S.A.). The proteins were subsequently trans ferred to nitrocellulose. After the transfer, the filters were washed in phosphate buffered saline, pH 7.4, dried, and blocked in 5% dry milk in Tris buffered saline, pH 7.4 con taining 0.2% Tween 20 (TBS-tween) overnight at +4°C. Filters were then either incubated for 2 hours at room temperature or overnight at +4°C with an antiphospho-JNK or antiphospho p38 antibody, or an antibody to phosphorylated extracellular signal regulated kinase (ERK) (Calbiochern) diluted 111000 in TBS-tween with 5% bovine serum albumin. The filters were subsequently washed three times and incubated for 120 minutes with a horseradish peroxidase secondary antibody (Dakopatts AlS) diluted 1/2000 in TBS-tween with 5% milk. After thor ough washing in TBS-tween (5 times for 30 minutes), proteins were visualized with enhanced chemiluminescence (Amer sham, U.K.). Molecular weight standards used for molecular weight estimations were from Bio-Rad (Hercules, CA, U.S.A.).
In vitro phosphorylation assays and immunocomplex kinase assay GST-c-Jun fusion protein (amino acids I to 79) and recom binant hsp27 were obtained from Calbiochem, and Stressgen Biotechnologies, Victoria BC, Canada, respectively, and phos phorylated as described by Sanghera et a!. (1996) . Thirty to forty fLg protein from cell extracts in 40 fLL of lysis buffer (described above), were incubated with I fLg of GST-c-Jun fusion protein or 0.5 fLg recombinant hsp27, 10 mmollL MgCI2, I mmol/L MnCI2, 50 fLmollL ATP, and 6 fLCi [ 3 2 Pl_ -yATP (3000 Cilmmol'L; Amersham Pharrnacia Biotech, Swe den) in a volume of 50 fLL. After samples were incubated for 30 minutes at +30°C, the reaction was stopped with the addi tion of SDS loading buffer. The proteins were separated on a 12% SDS-PAGE and transferred to supported nitrocellulose. Membranes were exposed to autoradiography film from 3 to 24 hours. Alternatively, the gel was dried and directly exposed to autoradiography film. For the immunocomplex kinase assay 500 fLg protein from total cell extracts were immunoprecipi tated for 2 hours at +4°C with the appropriate titer of an aga rose-conjugated anti-p38 antibody (Santa Cruz, Santa Cruz, CA, U.S.A.) that was able to precipitate the active kinases. The immunocomplexes were washed twice with lysis buffer, and twice with 10 mmollL Hepes, 10 mmollL (CH 3 COO}zMg con taining 0.1 mmollL Na 3 V04, and then suspended in 35fLL lysis buffer. The kinase reaction mix was then added as described above, and the immunoprecipitated active kinases were allowed to phosphorylate 1.6 fLg of GST -ATF2 fusion protein (Santa Cruz) for 30 minutes at 30°C. The reaction was stopped by the addition of SDS-loading buffer, and the proteins were separated on a 10% SDS-PAGE which was then dried and subjected to autoradiography for 2 to 4 days. In some experiments, the immunocomplexes were directly electrophorized on SDS PAGE, transferred to nitrocellulose, and blotted with an anti p38 antibody (the same as used for the immunoprecipitations but not conjugated to agarose) to verify the equal immunopre cipitation efficiency for all the differentially treated samples. Alternatively, cells were labeled with 3 5S-methionine for 1.5 hours, treated with LPS ± inhibitors, and total cell extracts were prepared. After immunoprecipitation with an agarose conjugated anti-p38 antibody, the 3 5S-labeled proteins were separated on SDS-PAGE, transferred to nitrocellulose, and sub jected to autoradiography.
Electrophoretic mobility shift assays
Nuclear extracts were isolated essentially as described by Struhl (1993(1) with minor modifications. In brief, the cells derived from two 150 mm petri dishes were washed twice and harvested in ice-cold phosphate-buffered saline, and then pel leted by centrifugation at 1,850x g for 10 minutes. The super natant was discarded, and the cell pellet was washed once in 5 volumes of hypotonic buffer (10 mmollL Hepes, pH 7.9, 1.5 mmollL MgCI2, 10 mmollL KCI, 0.2 mmollL PMSF, 0.5 mmollL DTT). The cells were resuspended in 3 volumes of hypotonic buffer and allowed to swell on ice for 10 minutes before homogenization in a glass Dounce homogenizer. The nuclei were pelleted by centrifugation at 3,400x g for 15 min utes and resuspended in 250 fLL of low salt buffer (20 mmollL Hepes, pH 7.9, 25% glycerol, 1.5 mmollL MgCI2, 10 mmollL KCI, 0.2 mmollL EDTA, 0.2 mmollL PMSF, 0.5 mmollL DTT). Then, KCI 2.5 mollL was added dropwise and under continuous mixing to a final salt concentration of 0.4 mollL; the nuclei were incubated for 30 minutes at +4°C under gentle agitation. The lysed nucleic debris were pelleted by centrifu gation at 25,000x g for 30 minutes at +4°C. The nuclear protein extracts remaining in the supernatant were aliquoted and im-A. SIMI ET AL. mediately frozen at -70°C. Protein concentration was deter mined by the Bradford method. The reactions were carried out in a total volume of 20 fJ-L with 4 to 8 fJ-g of nuclear protein and a final concentration of 30 mmollL Hepes, pH 7.9, 20% glyc erol, 2.25 mmollL MgCI 2 , 0.2 mmollL EDTA, 0.12 mmollL PM SF, 0.5 mmollL DTT, 0.1 fJ-g/fJ-L poly[d(I-C) d(I-C). The final salt concentrations were 200 mmollL KCI for AP-I and 130 mmollL NaCl for NF-KB incubated reactions. The double stranded AP-I or NF-KB probes were 3 2P-end-labeled using T4 polynucleotide kinase and e2Pl-'1ATP. For competition con trols, a 25-or 50-fold molar excess of the AP-I and the NF-KB double-stranded oligonucleotides was used. The DNA-protein complexes were separated on a 4% nondenaturing polyacryl amide gel in Tris/glycine buffer (50 mmollL Tris, 380 mmollL glycine, 2 mmol/L EDTA) at +4°C. The protein components of the retarded AP-l complex were identified by using specific antibodies against the c-Fos and c-Jun proteins, as well as a Jun antibody recognizing all members of lun family (mainly c-lun, and with lower affinity JunB and JunD) in the incubation re action (the antibodies were purchased from Calbiochem, LaJolla, CA, U.S.A., and Santa Cruz, respectively). The NF-KB time of treatment retarded complex was investigated using I fJ-g per lane of p65 and p50 antibody (Santa Cruz). The probes used had the fol lowing nucleotide sequences: 5' -CGCTTGATGACTCAGCC GGAA -3' for the consensus AP-I probe, 5'-AGTTG AGGGGACTTT CCCAGGC-3' for the consensus NFKB probe, and 5' -AGTTGAGGCGACTTT CCCAGGC-3' for the mutated NFKB probe.
Transient transfections
SK-N-MC human neuroblastoma cells and primary cortical glial cultures were grown to approximately 50% to 60% con fluence and were then transfected by means of DMRIE-C agent (Life). Cells were transfected in Optimem medium (Life) with a luciferase reporter plasmid containing seven AP-I response elements and an expression plasmid encoding mitogen acti vated protein kinase kinase kinase I (MEKK 1) (all from Strata gene, CA, U.S.A.). SK-N-MC cells were transfected with 0.5 to I fJ-g of AP-I firefly luciferase plasmid and, as a positive con trol, 25 ng of MEKK I expression plasmid, to cells on a plate with an area of 3.8 cm2. Primary cortical glial cultures were transfected with 0.5 to I fJ-g of AP-l firefly luciferase plasmid analyzed by quantitative AT-PCA. C represents CMZ treatment alone (for 6 hours). Maximal induction of c-fos at 30 minutes was statistically significant (P = 0.0061) and the percentage inhibition by CMZ on the LPS induction (100%) exhibited P < 0.0001. Maximal induction of c-jun mANA after 30 minutes of LPS treatment and the percentage inhibition by CMZ was also statistically significant (P = 0.0116, P = 0.0016, respectively). At 3 hours of LPS treatment, c-jun mANA induction by LPS and the percentage inhibiton by CMZ exhibited P = 0.0456 and P = 0.0002, respectively. (C) Aepresentative Northern hybridization experiment for c-fos mANA (Con, control; L, LPS; T, TPA). (D) Dose dependency of CMZ for inhibition of c-fos mANA levels in primary cortical glial cells treated with LPS for 30 minutes. A representative out of three independent experiments was calculated with quantitative AT-PCR. The magnitude of maximal inhibition by CMZ was only 50%, whereas the mean of inhibition seen at 40 IJmollL in 7 independent experiments was -65%. 
Data analysis
For statistical evaluations of the results, Student's unpaired I-test was used as only two parameters (two different treatments in this case) were compared. Each independent experiment con stitutes an independent preparation of RNA or cell extract from different cell culture preparations. The value of each experi ment is the mean of the replicate samples (usually double or triple) of the same treatment.
For the quantitative RT-PCR mimic analysis, the calcula tions were at the linear range when target to mimic DNA ratios were between 0.66 to 1.55 (the relative content of target cDNA of each sample was calculated from the linear regression of the target-mimic DNA ratio versus concentration of mimic for 3 to 4 different mimic concentrations). Values obtained for indi vidual samples were always divided with the f3-actin content of each sample.
In all experiments, the P values were calculated on the per centage induction or percentage inhibition when the value of the control (no treatment) or induced sample (LPS or gluta mate) was taken as 100%.
RESULTS
Effects of chlomethiazole on c-fos and c-jun mRNA expression
The time dependence of c-fos and c-jun mRNA induc tion upon LPS treatment in primary cortical glial cells was characterized by using a quantitative RT-PCR assay and Northern blot analysis. The expression of c-fos mRNA was induced as early as 15 minutes by LPS treat ment and the maximal induction, usually up to 4-to 5-fold, was observed in most experiments at 30 minutes (Fig. lA) . The time dependence of c-fos mRNA in re sponse to LPS was characterized by a rapid and transient increase (15 to 60 minutes) followed by a postinduc tional suppression phase at 6 hours and a tendency to be up-regulated again at 15 hours, the latest time point ex amined. The induction by LPS at 15 and 30 minutes was inhibited by CMZ by 60% to 70% when administered 1 hour before LPS at a dose of 40 ].LmoliL (Fig. lA) . In duction of c-jun mRNA by LPS was up to 4.5-fold and the time point of maximal induction varied some what. Maximal induction was usually observed at 30 to 60 minutes and up to 3 hours of LPS treatment. Chlomethiazole, at a dose of 40 ].LmollL, potently in hibited the induction of c-jun mRNA at all time points (Fig. 1 B) .
Apart from LPS, in several experiments primary cor tical glial cells were also stimulated with TP A, a strong activator of c-fos. TPA treatment for 30 minutes caused a more than 20-fold induction of c-fos mRNA levels, as quantified by RT-PCR mimic, but 40 or 60 ].Lmol/L CMZ could not attenuate this induction (Fig. I C) . The dose dependence to CMZ was analyzed on c-fos mRNA in duction after 30 minutes of LPS treatment, and the ICso value for CMZ was calculated to equal approximately 2 ].LmollL (see Fig. lD) .
To examine the potential involvement of p38 MAP kinases in the induction of c-fos and c-jun mRNA levels by LPS, SB203580, a potent inhibitor of the activity of p38cx, p38�, and p38�2 isoforms of p38 MAP ki nase was added to cortical glial cultures 1 hour before LPS. In three independent experiments (Fig. 2) , 10 ].LmollL SB203580 was sufficient to inhibit the LPS mediated induction of both c-fos and c-jun mRNA by 70% to 80%.
Chlomethiazole inhibits AP-l DNA binding and transactivation
The AP-I DNA binding activity upon LPS treatment was assayed by electrophoretic mobility shift assay in nuclear extracts from primary cortical glial cultures. The Effect of 88203580 on c-fos and c-jun mRNA. Total RNA was isolated from rat primary cortical glial celis treated with LP8 for 30 minutes with or without inhibitors. 88203580 or CMZ was added to the celis 1 hour before LP8 at a dose of 10 and 40 JJmollL respectively. After formaldehyde denaturing gel electro phoresis, 40 JJg RNA were hybridized to c-fos, c-jun or f3-actin 32P-labeled DNA probes. A representative out of three indepen dent experiments is shown.
DNA probe was a consensus AP-l element, which is known to bind Fos and Jun heterodimers with high af finity, as well as Jun-Jun homodimeric complexes. As shown in Fig. 3A , there was an increase in the DNA binding detected after 9 hours of LPS treatment which was counteracted by CMZ. Treatment with TP A was also shown as a positive control. The AP-l complex was found to consist of c-Fos and c-Jun heterodimers, as revealed from antibody interference-supershift analysis, in which the LPS-induced AP-l band was reduced in the presence of two different c-Fos specific antibodies and a c-Jun specific antibody; whereas, the AP-l bond was completely abolished when an antibody recognizing JunB and JunD in addition to c-Jun was used. Further more, an antibody against GFAP, an astrocyte cytoskel eton protein, did not affect the specific AP-l binding as expected (Fig. 3B) . The specificity of the DNA-protein interactions was confirmed in competition experiments, in which a 25 or 50 times excess of cold AP-l oligo nucleotide probe abolished the binding only of the spe cific retarded band (Fig. 3B ).
Human SK-N-MC neuroblastoma cells were trans fected with an AP-l luciferase reporter plasmid contain ing seven consensus AP-l elements. One hundred f.LmollL glutamate gave a slightly greater than twofold increase in luciferase activity that was time dependent and peaked at approximately 3 hours. Chlomethiazole inhibited the glutamate-dependent AP-l activation to -70% to 80% at 30 to 60 f.LmollL in a highly reproduc ible manner (Fig. 3C) . The inhibition of glutamate in duced AP-l transactivation by CMZ was dose depen dent, with an estimated ICso of -8 f.LmollL.
Chlomethiazole has no effect on NFKB DNA-binding, IL-IP or TNF-a mRNA expression in response to LPS Compounds such as aspirin and sodium salicylate have been suggested to be neuroprotective through the inhibition of the transcription factor NFKB (Grilli et aI., 1996) ; therefore, the authors tested the effect of CMZ on NFKB binding to DNA. Lipopolysaccharide rapidly in duced the binding of protein complexes to an NFKB consensus probe in nuclear extracts from primary corti cal glial cultures (Fig. 4A) . The LPS-inducible protein complexes that bound to the consensus NFKB probe were identified as NFKB specific ones as they were: (I ) supershifted by p50 and p65 antibodies (Fig. 4A); (2) competed with excess probe, but not a mutated probe (one G4C mutation, Fig. 4A ); and (3) sensitive to known inhibitors of NFKB such as sodium nitroprusside or PDTC (not shown). Addition of 40 up to ISO f.LmollL CMZ 1 hour before LPS stimulation did not result in a change of binding to the NFKB probe.
The effect of CMZ on the mRNA expression of two proinflammatory cytokines, at least partially under the control of NFKB, was examined in primary cortical glial cultures. Lipopolysaccharide caused an approximately 200-fold increase in the mRNA levels of IL-I (3 after 9 hours of treatment, as measured by quantitative RT-PCR mimic. However, 60 f.LmollL CMZ did not show any inhibitory effect on IL-l (3 mRNA expression (Fig. 4B) . Lipopolysaccharide also caused a 2.5-fold increase of TNF-ex mRNA levels in these cells, as measured by quantitative RT-PCR mimic, which was not counteracted by CMZ at a dose of 60 f.LmollL (data not shown).
Lipopolysaccharide activates JNK and ERK
MAP kinase activation was studied with Western blot analysis of cortical glial cell extracts using antibodies against phospho-INK and phospho-ERK. These antibod ies recognized a 46 kDa band (JNK) and 42 and 44 kDa bands (ERK), respectively; whereas very weak phos phorylation of INK and ERK by LPS was seen at 10 to 15 minutes, and full activation was detected at 60 to 120 minutes. However, 60 f.Lmol/L CMZ did not show any inhibitory action on the activation of INK or ERK by LPS when added 30 to 60 minutes before LPS stimula tion (not shown). In addition, induction of c-fos mRNA by TPA, which is primarily acting through the ERK path way, was not inhibited by CMZ (Fig. lC) .
Lipopolysaccharide caused a substantial increase in the N-terminal phosphorylation of a GST -c-Iun, a fusion protein used as a substrate for INK, in an in vitro kinase assay using primary cortical glial cell extracts. The in crease in phosphorylation of GST-c-Iun was not affected by CMZ at 30 or 60 minutes (not shown). Chlomethia zole was ineffective in inhibiting GST -c-I un phosphor ylation when added to the cell culture or in vitro in the phosphorylation assay. In addition, primary cortical glial cultures were transfected with an AP-l luciferase re porter and a MEKK 1 expression plasmid, a MAP kinase kinase kinase upstream of INK previously shown to be activated by LPS in macrophages (Sanghera et aI., 1996) . MEKK 1 cotransfections resulted in a potent and dose dependent increase in AP-l luciferase activity. Chlome thiazole (60 f.LmollL) did not counteract this induction under conditions in which MEKKI was limiting (that is, low concentrations of plasmid) nor under any of several different time aspects examined (not shown).
Phosphorylation of p38 MAP kinase is unaffected by chlomethiazole
Phosphorylation of p38 MAP kinase was analyzed vith a phospho-p38 antibody in a Western blot assay of primary cortical glial cultures. The antibody recognized a single band with mobility corresponding to -40 kDa that was found to be reactive within 10 minutes of LPS treat ment and remained reactive for at least 120 minutes, the longest time point analyzed. The phosphorylation status of p38 MAP kinase was not altered by the 60 f.LmollL CMZ added 45 minutes before LPS (Fig. SA) .
Chlomethiazole inhibits the phosphorylation of the p38 MAP kinase substrates hsp27 and A TF-2
Because p38 MAP kinase activity, but not phosphor ylation status, was shown to be inhibited by SB203580 and equivalent pyridinyl imidazoles , the authors examined the effect of CMZ on p38 MAPK activity towards two downstream effectors-the indirect target hsp27, which lies downstream of MAPKAP-K2, and the direct p38 MAPK substrate ATF-2. To assess the phosphorylation of hsp27, the authors used an in vitro kinase assay in which kinases present in total cell ex tracts from primary cortical glial cells were allowed to phoshorylate in vitro recombinant hsp27 in the presence of e 2 PJ-),ATP. A slightly greater than twofold increase in the phosphorylation of hsp27 was seen after 10 min utes of LPS treatment. Chlomethiazole, at a dose of 40 f.LmollL, inhibited this increase to 50% at both 10 and 30 minutes of LPS treatment (Fig. 5B) . The LPS-induced phosphorylation of hsp27 was found to be dependent on p38 MAP kinase, as it was inhibited by SB203580 added ill vitro in the incubation by almost 90% (Fig. 5B ). Li popolysaccharide further induced the phosphorylation of a GST-ATF-2 fusion protein by 2-to 3-fold maximally at 30 minutes, as assayed in total cell extracts from rat cortical glial cultures. The increased phosphorylation of GST-ATF-2 was also inhibited by CMZ either when the drug was added in cell cultures 1 hour before LPS, or when added in vitro in the kinase assay (not shown). In addition to CMZ, GST-ATF-2 phosphorylation was sen sitive to 10 f.Lmol/L SB203580, but only when the com pound was added in vitro in the kinase assay (data not shown).
Because ATF-2 is also substrate for INK, immunopre cipitation experiments were carried out using an agarose conjugated specific antibody against p38 MAP kinase isoforms ex and (3. Immunocomplex kinase assays using GST-ATF-2 as a substrate showed an induction at 30 minutes by LPS that was counteracted by 40 f.LmollL chlomethiazole (Fig. 6) . The phosphorylation of GST ATF-2 by p38 MAPK immunoprecipitates was sensitive to SB203580 (10 f.LmoI/L) when added ill vitro in the kinase reaction, whereas it was sensitive to chlomethia zole (40 f.LmollL) when added either in the cell culture media or in the kinase reaction (Fig. 6B) . When a GST c-Iun fusion protein was used as a substrate in the same assay, no phosphorylated band was detected, indicating (1) free probe;
(2) control extract; (3) LPS stimulated ex tract (100 ng/mL for 1 hour); and (4) extract treated with 100 I-ImollL of CMZ 1 hour before treatment with LPS (100 ng/mL) for 1 hour. In lanes 5 to 10, the same LPS stimulated extract shown in lane 3 was treated with antibodies or competing DNA probes. In lanes 5 and 6, p50 and p65 antibodies, respectively, were added to the extracts 30 minutes before incubation with probe. In lanes 7 and 8, a 20-and 50-fold molar excess, respectively, of cold probe was present in incubation mixtures, and in lanes 9 and 10 a 20-and 50-fold molar excess, respectively, of a cold NFKB probe carrying a G---> C mutation was present in incubation mix tures. (8) IL-1() mRNA: Total RNA from rat cortical glial cells treated with LPS, or CMZ, or both for 9 hours was reverse tran scribed using oligo-dT primer and amplified in the presence of different concentrations of a standard DNA competitor (mimic DNA) for 35 cycles. The PCR products were analyzed on a 1.6% agarose/TBE gel and visualized at UV light using ethidium bro mide staining. The lower band is the target IL-1 () cDNA fragment and the upper band is the mimic DNA. For all samples a series of four different fivefold dilutions of the mimic DNA were used (de creasing from left to right).
the absence of JNK in the anti-p38 immunoprecipitates (Fig. 6, lane 6) . The quantitative nature of the p38 im munocomplex kinase assay was verified in experiments in which immunocomplexes from differently treated J Cereb Blood Flow Metab. Vol. 20, No. 7, 2000 cells were found to contain the same amount of immu noprecipitated kinases when analyzed by Western blot using the same anti-p38 antibody or by autoradiography from 35 S-methionine-Iabeled cells (not shown).
DISCUSSION
We have found that chlomethiazole specifically at tenuates the induction of c-fa s, c-jun, and AP-l in re sponse to LPS in rat primary cortical glial cells, mainly consisting of astrocytes. It was also found that chlome thiazole counteracted AP-l transactivation in response to glutamate in human SK-N-MC neuroblastoma cells. The inhibitory effect was seen in several different assays, including quantitative RT-PCR, Northern blot, electro phoretic mobility shift assay, and transfectional analysis.
U sing several different experimental approaches we found no evidence for an effect of CMZ in ERK or JNK MAP kinase pathways, or in NFKB activation. Instead, we found that the phosphorylation of hsp27 and ATF-2 by cell extracts and p38 immunoprecipitates, respec tively, was sensitive to CMZ. As phosphorylation of p38 MAPK was unaltered by CMZ, therefore we concluded 47- 10 IJmol/L, respectively) on the LPS-induced phosphorylation of GST-ATF-2 are compared, as assessed by the p38 MAPK im munocomplex kinase assay in cortical glial cells. The inhibitors were added in the cells 1 hour before LPS or in vitro during the kinase assay incubations (*) . P values for each inhibitor were calculated on the percentage inhibition of the LPS-induced ATF-2 phosphorylation (taken as 100%) by means of Student's unpaired t-test and are the following: LPS+CMZ (P = 0.0037) versus LPS 30' (n = 6), LPS+S8203580 (P = 0.279) versus LPS 30' (n = 4), LPS+CMZ added in vitro (P = 0.0159) versus LPS 30' (n = 5), and LPS+ S8203580 added in vitro (P = 0.0003) versus LPS 30' (n = 6).
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that the compound inhibits kinase activity directly at the level of p38 MAP kinase. In support of this, we found that SB203580 and CMZ displayed similar characteris tics in a number of different experiments. They both (1) inhibited c-fos and c-jun mRNA induction, (2) inhibited hsp27 and ATF-2 phosphorylation in kinase assays, and (3) interfered with p38 immunoprecipitable catalytic ac tivity without affecting the phosphorylation of p38 MAP kinase itself. In addition, we found no evidence of alter ations in ERK or JNK pathways in the presence of CMZ, as had previously been reported for SB203580 (Cohen, 1997) .
A mechanism in which CMZ acts to attenuate p38 MAPK activity suggested that the compound has promi nent anti-inflammatory properties. It has been shown that CMZ is highly effective as a neuroprotectant in many different animal models of cerebral ischemia (Green, 1998) , models in which inflammatory factors such as the cytokine IL-I 13 might be of importance (Rothwell and Relton, 1993; Yamasaki et aI., 1995) . It has also been shown that other cytokines such as TNF-a and IL-6 might assume modulatory roles during cerebral ischemia (Maeda et aI., 1994; Bruce et aI., 1996) . In many cells p38 MAP kinase has a role in regulation of biosynthesis of cytokines such as IL-113 and TNF-a, and the p38 MAP kinase inhibitor SB239063 has been found to reduce brain injury and neurologic deficits in models of MCA occlusion (Barone et ai, 1999) . Importantly, it was re cently found that p38 MAP kinase is activated predomi nantly in astrocytes during cerebral ischemia (Irving et ai, 1999) , indicating a crucial role for astrocytes in regu lation of p38 MAP kinase dependent responses of the CNS during ischemia. Except for glial cells, several re ports have also demonstrated the contribution of stress activated protein kinases of the JNK and p38 families in nervous tissue excitotoxicity and apoptosis, and in isch emia of the heart. Both JNK and p38 MAP kinases were found to be activated during nerve growth factor with drawal or glutamate exposure and were implicated in a proapoptotic pathway (Xia et aI., 1995; Mukherjee et aI., 1999) . Interestingly, the pyridinyl imidazole SB203580 has been found to potently counteract induction of ap optosis by glutamate in cerebellar granule cells (Ka wasaki et aI., 1997) in which similar concentrations of SB203580 were needed for inhibition of p38 MAP ki nase as were for inhibition of apoptosis. Recently, it was also suggested that SB203580 might attenuate cell injury in response to ischemia in cardiac myocytes (Mackay and Mochly-Rosen, 1999) . Taken together, much evi dence favors a role of p38 MAP kinases in ischemic and apoptotic injury of cells of the central nervous system, and it has been suggested that the ability of CMZ to inhibit p38 MAP kinase activity contributes to the neu roprotective properties of the compound. Based on the above outlined evidence, we believe that the in vitro models employed in the current investigation are rel evant for studies of inflammatory responses of cells of the central nervous system during ischemia.
The mechanism employed by CMZ for inhibition of AP-l in SK-N-MC human neuroblastoma cells is yet to be elucidated. However, it is very interesting that CMZ also affects the same or similar responses in neuronal cells and that it interferes with early events in stroke like glutamate-mediated responses.
The sedative, hypnotic, and anxiolytic properties of CMZ have previously been ascribed to the potentiation of the action of GABA at the GABAA receptor complex (Moody and Skolnick, 1989; Hales and Lambert, 1992) . Although the relation of the inhibition of c-fos/c-junl AP-I seen to the GABAA mimetic properties of CMZ has not been directly addressed in the current study, we consider it unlikely that GABAA is involved in the action of CMZ seen in these studies for two reasons. First.
whereas CMZ inhibited c-fo s expression with an ICso of -2 fLmol/L, CMZ has been reported to enhance picro toxin-sensitive chloride uptake with an ECso of 48 fLmollL and to displace binding of t-butylbicyclophos phorothionate, a compound that binds to a site associated with the chloride channel, with an ICso of 58 to 150 fLmollL in different studies (Cross et al., 1989; Moody and Skolnick, 1989; Green, 1998) . Secondly, although GABAA receptors are highly expressed in glial ceIls in vivo, astrocytes have been reported not to express these receptors at significant levels in vitro (Bureau et ai., 1995; Hosli et ai., 1997) . Notably, CMZ has recently been shown to attenuate the inflammatory response to chronic ethanol treatment of the liver (Fang et ai., 1998) , a tissue which, to our knowledge, does not express GABAA receptors.
Several different transcription factors known to bind to either c-fos, or c-jun promoters, or both, have been shown to potentially lie downstream of p38 MAP ki nases; these include MEF2C (Han et ai., 1997) , CREB (Tan et aI., 1996; Deak et ai., 1998; Xing et ai., 1998) , Elk-l (Raingeaud et ai., 1996) and ATF-2, an excellent in vitro substrate for several JNK and p38 MAP kinase isoforms (Gupta et ai., 1995; Jiang et ai., 1996; Goedert et ai., 1997) although its role in vivo is less clear and may depend on the cell type studied (Hazzalin et aI, 1996; Hazzalin et ai, 1997; Chen et ai, 1998; Cheong et ai, 1998) . LPS-induced transcription of c-jun has been shown to be, to a large extent, dependent on a MEF2C binding site. Binding to this element is inhibited to 65% by SB203580, and mutation of this site inhibits LPS induced c-jun transcription (Han et ai., 1997) . Accord ingly, it is a distinct possibility that CMZ inhibits c-jun mRNA induction by inhibiting transactivation through the MEF2C site. Transcription of cJos in fibroblasts in duced by UY radiation or anisomycin, but not by growth factors or phorbol ester, has been shown to be sensitive to SB203580 (Hazzalin et ai., 1996) . Thus, LPS effects on c�fos in primary cortical glial cells resemble the former group. It has been suggested (Cohen, 1997 ) that the serum response element and cyclic AMP response element are important for c-fo s transcription in response to stressful stimuli as their activation is sensitive to SB203580 (Tan et ai., 1996; Ahn et ai., 1998) . A possible hypothesis is that CMZ effects on cJos are mediated through the serum response elements, or cyclic AMP response elements, or both. However, further studies are required for direct identification of CMZ sensitive ele ments of c-fo s and c-jun promoters.
J Cereb Blood Flo)\' Metah, Vol. 20, No. 7, 2000 In conclusion, we have found that CMZ acted as an inhibitor of p38 MAP kinase catalysis, and that expres sion of the early genes cJos and c-jun in response to LPS can be attenuated. Inhibition of p38 MAPK occurred through direct interaction with p38, or an associated pro tein, as CMZ was effective in in vitro kinase assays but did not affect phosphorylation of p38 MAP kinase. The results described a novel mechanism of action of CMZ that because of dose-response relations was suggested to be of relevance for the neuroprotective properties of CMZ previously seen by others.
